Maxigen Biotech Inc (1783)

Currency in TWD
39.30
-0.15(-0.38%)
Delayed Data·
1783 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
39.2039.75
52 wk Range
37.8048.85
Key Statistics
Bid/Ask
36.40 / 36.50
Prev. Close
43
Open
39.45
Day's Range
39.2-39.75
52 wk Range
37.8-48.85
Volume
91.12K
Average Volume (3m)
104.86K
1-Year Change
-10.1714%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1783 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Maxigen Biotech Inc News & Analysis

Show more
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 13, 2026
EPS / Forecast
0,93 / --
Revenue / Forecast
224,71M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.02%
Dividend Yield
1.93%
Industry Median 5.02%
Annualised payout
0.83
Paid annually
5-Years Growth
+4.21%
Growth Streak

1783 Income Statement

Compare 1783 to Peers and Sector

Metrics to compare
1783
Peers
Sector
Relationship
P/E Ratio
13.0x−59.0x−0.5x
PEG Ratio
0.43−0.730.00
Price/Book
2.2x29.2x2.6x
Price / LTM Sales
4.3x5.0x3.2x
Upside (Analyst Target)
-28.2%48.3%
Fair Value Upside
Unlock3.3%5.6%Unlock

Maxigen Biotech Inc. researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally. It operates through two segments, Biomedical Products and Consumer Products. The company provides biomedical materials, such as collagen and bone supplements; beauty and skincare products; and medical devices for ophthalmology, otolaryngology, dental, surgical, orthopedics, electronic instructions for use, and medical aesthetics, as well as engages in collagen purification activities. It also offers ophthalmic viscoelastic under the PreviscAid, ViscAid, and BiVisc brands; intra-articular injections under the ArtiBest and ArtiAid brands; synthetic bone grafts under the BestAid, GingivAid, FormaGraft, and Foramic brands; and dermal filler injections under the Formaderm brand. In addition, the company provides collagen based regenerative matrixes comprising HealiAid, a collagen wound dressing; NasoAid, an intranasal splint; and FormaAid, a collagen membrane. Maxigen Biotech Inc. was incorporated in 1998 and is headquartered in Taoyuan City, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
422,60K0,47%16,67M
Other Institutional Investors
50,91M56,77%2,01B
Public Companies & Retail Investors
38,34M42,76%1,51B
Total
89,68M100,00%3,54B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
TCI Co., Ltd.30,09%26 983 7621 064 509
Formosa Chemicals & Fibre Corporation9,70%8 702 040343 295

FAQ

What Is the MBI (1783) Stock Price Today?

The MBI stock price today is 39,30 TWD.

What Stock Exchange Does MBI Trade On?

MBI is listed and trades on the Taiwan Stock Exchange.

What Is the Stock Symbol for MBI?

The stock symbol for MBI is "1783."

Does MBI Pay Dividends? What’s The Current Dividend Yield?

The MBI dividend yield is 1.93%.

What Is the MBI Market Cap?

As of today, MBI market cap is 3,52B TWD.

What Is MBI's Earnings Per Share (TTM)?

The MBI EPS (TTM) is 3,02.

From a Technical Analysis Perspective, Is 1783 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has MBI Stock Split?

MBI has split 3 times.

What is the current trading status of MBI (1783)?

As of May 07, 2026, MBI (1783) is trading at a price of 39,30 TWD, with a previous close of 43,00 TWD. The stock has fluctuated within a day range of 39,20 TWD to 39,75 TWD, while its 52-week range spans from 37,80 TWD to 48,85 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.